| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4180fc57a693864e2ce2dbfd64a9278 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-341 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-335 |
| filingDate |
2005-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8220a7a5cf1916fa09e1c91bd9e6735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d329062033a144bfb40f7cab20b8925
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45b7f60bb1448649f199716741a0633c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d742f8a51c334ac6b2d27ca48803bdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80172bef4dffce387966fb132792647f |
| publicationDate |
2010-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ME-P21108-A |
| titleOfInvention |
FUROSEMIDE DERIVATIVES AS HM74N MODULATORS AND THEIR APPLICATION FOR INFLAMMATION TREATMENT |
| abstract |
Host cells expressing HM74 were used to obtain furosemide-like molecules having agonistic activity and the following structural formula: |
| priorityDate |
2004-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |